Monday, 21 Sep 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Finance
  • Clinical trial results
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Hengrui's Trastuzumab Rezetecan Granted FDA Orphan Drug Designation for Gastric Cancer Treatment
CompanyDrug

Hengrui’s Trastuzumab Rezetecan Granted FDA Orphan Drug Designation for Gastric Cancer Treatment

August 12, 2025
Pfizer's Q2 2025 Revenue Rises 10% Driven by Strong Biopharma Sales
Company

Pfizer’s Q2 2025 Revenue Rises 10% Driven by Strong Biopharma Sales

August 6, 2025
Novo Nordisk Reports Strong H1 2025 Financial Results Driven by Semaglutide Sales
Company

Novo Nordisk Reports Strong H1 2025 Financial Results Driven by Semaglutide Sales

August 6, 2025
Qyuns Therapeutics' QX004N Enters Phase 3 Trials for Psoriasis and Crohn’s Disease
CompanyDrug

Qyuns Therapeutics’ QX004N Enters Phase 3 Trials for Psoriasis and Crohn’s Disease

August 6, 2025
Sino Biopharmaceutical's TQC3302 Approved for COPD Maintenance Treatment Clinical Trials
CompanyDrug

Sino Biopharmaceutical’s TQC3302 Approved for COPD Maintenance Treatment Clinical Trials

August 6, 2025
Humanwell Healthcare Receives NMPA Approval for HW241045 IPF Clinical Trials
CompanyDrug

Humanwell Healthcare Receives NMPA Approval for HW241045 IPF Clinical Trials

August 26, 2025
Everest Medicines' Nefecon Granted Full Approval by Taiwan's TFDA for IgA Nephropathy
CompanyDrug

Everest Medicines’ Nefecon Granted Full Approval by Taiwan’s TFDA for IgA Nephropathy

August 6, 2025
CSPC Pharmaceutical's Semaglutide Injection NMPA Marketing Application Accepted
CompanyDrug

CSPC Pharmaceutical’s Semaglutide Injection NMPA Marketing Application Accepted

August 6, 2025
Hebei Senlang's SENL103 CAR-T Therapy Approved for Refractory Generalized Myasthenia Gravis in China
CompanyDrug

Hebei Senlang’s SENL103 CAR-T Therapy Approved for Refractory Generalized Myasthenia Gravis in China

August 6, 2025
ChemPartner and Leado Pharma Sign Strategic Agreement to Advance New Drug R&D
CompanyDeals

ChemPartner and Leado Pharma Sign Strategic Agreement to Advance New Drug R&D

August 5, 2025
Zhongheng Group Acquires Patent for Innovative Chronic Heart Failure Drug LZ-01
CompanyDeals

Zhongheng Group Acquires Patent for Innovative Chronic Heart Failure Drug LZ-01

August 5, 2025
Gaush Meditech's Frequency-Domain Biometer Gains Medical Device Registration in Jiangsu
CompanyMedical Device

Gaush Meditech’s Frequency-Domain Biometer Gains Medical Device Registration in Jiangsu

August 5, 2025
1 2 … 15 16 17 18 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up